(Q34381172)

1 August 2017

1 reference

title

Cytotoxic treatment of adrenocortical carcinoma (English)

1 reference

1 August 2017

0 references

5

Nilsson O

1 reference

1 August 2017

3

Jansson S

1 reference

1 August 2017

Ahlman H

1

1 reference

1 August 2017

Khorram-Manesh A

2

1 reference

1 August 2017

Wängberg B

4

1 reference

1 August 2017

Jacobsson CE

6

1 reference

1 August 2017

Lindstedt S

7

1 reference

1 August 2017

1 July 2001

1 reference

1 August 2017

World Journal of Surgery

1 reference

1 August 2017

25

1 reference

1 August 2017

7

1 reference

1 August 2017

927-933

1 reference

https://scigraph.springernature.com/pub.10.1007/s00268-001-0031-6

1 August 2017

0 references

cites work

Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell line

1 reference

https://api.crossref.org/works/10.1007%2FS00268-001-0031-6

Radiation therapy of adrenal cortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-001-0031-6

Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-001-0031-6

Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-001-0031-6

Treatment of adrenal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-001-0031-6

Treatment of Adrenocortical Carcinoma with o,p'-DDD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-001-0031-6

Cushing's syndrome. Therapy directed at the adrenal glands

21 January 2018

1 reference

12 December 2020

SURAMIN FOR TREATMENT OF ADRENOCORTICAL CARCINOMA

1 reference

12 December 2020

Modulation of cytotoxic drug activity by mitotane and lonidamine in human adrenocortical carcinoma cells.

1 reference

12 December 2020

Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect.

1 reference

12 December 2020

Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy

1 reference

12 December 2020

5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma

1 reference

12 December 2020

Adrenocortical carcinoma

1 reference

12 December 2020

Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up

1 reference

12 December 2020

Comment--Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma?

1 reference

12 December 2020

An eleven-year experience with adrenocortical carcinoma

1 reference

12 December 2020

Cis-platinum treatment of metastatic adrenal carcinoma

1 reference

12 December 2020

Mitotane failure in adrenocortical cancer: where next?

1 reference

12 December 2020

P-glycoprotein expression and multidrug resistance in adrenocortical carcinoma.

1 reference

12 December 2020

Cytotoxic chemotherapy in adrenal cortical carcinoma

1 reference

12 December 2020

Adrenal cortical carcinoma. A clinical and pathologic study of 49 cases

1 reference

12 December 2020

Ketoconazole treatment in Cushing's syndrome: experience in 34 patients

1 reference

12 December 2020

Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.

1 reference

12 December 2020

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.

1 reference

12 December 2020

The distribution of o,p'-DDD (mitotane) among serum lipoproteins in normo- and hypertriglyceridemia

1 reference

12 December 2020

Mitotane Enhances Cytotoxicity of Chemotherapy in Cell Lines Expressing a Multidrug Resistance Gene (mdr-1/P-Glycoprotein) which is also Expressed by Adrenocortical Carcinomas

1 reference

12 December 2020

The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring

1 reference

12 December 2020

Adrenocortical carcinoma: experience in 45 patients

1 reference

12 December 2020

In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors.

1 reference

12 December 2020

Adrenal cortical carcinoma--a continuing challenge

1 reference

12 December 2020

Regression of metastatic adrenal carcinoma during palliative ketoconazole treatment

1 reference

12 December 2020

CLINICAL AND PATHOPHYSIOLOGIC ASPECTS OF ADRENOCORTICAL CARCINOMA.

1 reference

12 December 2020

Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors

1 reference

12 December 2020

Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study

1 reference

12 December 2020

Complete response of metastasized adrenal cortical carcinoma with o,p'-ddd.Case report and literature review

1 reference

12 December 2020

Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases

1 reference

12 December 2020

Eastern Cooperative Oncology Group study 1879: mitotane and adriamycin in patients with advanced adrenocortical carcinoma

1 reference

12 December 2020

An in vitro and in vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma

1 reference

12 December 2020

Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers

1 reference

12 December 2020

Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16)

1 reference

12 December 2020

Adrenal cortical carcinoma

1 reference

12 December 2020

Treatment of metastatic adrenal cortical carcinoma with etoposide (VP-16) and cisplatin after failure with o,p'DDD. Clinical case reports

1 reference

12 December 2020

Mitotane Use in Inoperable Adrenal Cortical Carcinoma

1 reference

12 December 2020

Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer

1 reference

12 December 2020

Preoperative ketoconazole therapy for adrenocortical carcinoma

1 reference

12 December 2020

Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature

1 reference

12 December 2020

Peripheral antiglucocorticoid action of RU 486 in man

1 reference

12 December 2020

Adrenocortical carcinoma. A retrospective study of a rare tumor with a poor prognosis

1 reference

12 December 2020

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

1 reference

12 December 2020

Natural history of adrenal cortical carcinoma: A clinicopathologic study of 42 patients

1 reference

12 December 2020

Adrenocortical carcinoma. A clinical study and treatment results of 52 patients

1 reference

12 December 2020

Effects of suramin on the function and structure of the adrenal cortex in the cynomolgus monkey

1 reference

12 December 2020

CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinoma

1 reference

12 December 2020

Adrenal cortical carcinoma

1 reference

12 December 2020

Cisplatin for adrenal cortical carcinoma

1 reference

12 December 2020

Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome

1 reference

12 December 2020

Carcinoma of the adrenal cortex: clinical description, diagnosis, and treatment.

1 reference

12 December 2020

Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery

1 reference

12 December 2020

Lonidamine: in vitro/in vivo correlations

1 reference

12 December 2020

[Treatment of malignant adrenal cortex carcinoma]

1 reference

12 December 2020

Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients

1 reference

12 December 2020

Oral gossypol in the treatment of metastatic adrenal cancer

1 reference

12 December 2020

10.1007/S00268-001-0031-6

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference